25 XP   0   0   10

Destiny Pharma PLC
Buy, Hold or Sell?

Let's analyse Destiny Pharma PLC together

PenkeI guess you are interested in Destiny Pharma PLC. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Destiny Pharma PLC. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Destiny Pharma PLC

I send you an email if I find something interesting about Destiny Pharma PLC.

Quick analysis of Destiny Pharma PLC (30 sec.)










What can you expect buying and holding a share of Destiny Pharma PLC? (30 sec.)

How much money do you get?

How much money do you get?
p0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
p8.00
Expected worth in 1 year
p8.49
How sure are you?
55.6%

+ What do you gain per year?

Total Gains per Share
p0.49
Return On Investment
2.3%

For what price can you sell your share?

Current Price per Share
p21.50
Expected price per share
p15.55 - p28.00
How sure are you?
50%

1. Valuation of Destiny Pharma PLC (5 min.)




Live pricePrice per Share (EOD)

p21.50

Intrinsic Value Per Share

p-76.25 - p-69.47

Total Value Per Share

p-68.25 - p-61.47

2. Growth of Destiny Pharma PLC (5 min.)




Is Destiny Pharma PLC growing?

Current yearPrevious yearGrowGrow %
How rich?$9.5m$9.3m$145.4k1.5%

How much money is Destiny Pharma PLC making?

Current yearPrevious yearGrowGrow %
Making money-$8.1m-$6.6m-$1.4m-17.9%
Net Profit Margin-4,209.5%-3,954.4%--

How much money comes from the company's main activities?

3. Financial Health of Destiny Pharma PLC (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

What can you expect buying and holding a share of Destiny Pharma PLC? (5 min.)

Welcome investor! Destiny Pharma PLC's management wants to use your money to grow the business. In return you get a share of Destiny Pharma PLC.

What can you expect buying and holding a share of Destiny Pharma PLC?

First you should know what it really means to hold a share of Destiny Pharma PLC. And how you can make/lose money.

Speculation

The Price per Share of Destiny Pharma PLC is p21.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Destiny Pharma PLC.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Destiny Pharma PLC, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is p8.00. Based on the TTM, the Book Value Change Per Share is p0.12 per quarter. Based on the YOY, the Book Value Change Per Share is p-5.17 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is p0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Destiny Pharma PLC.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 p% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Share
Usd Eps-0.09-0.4%-0.09-0.4%-0.07-0.3%-0.07-0.3%-0.05-0.2%
Usd Book Value Change Per Share0.000.0%0.000.0%-0.06-0.3%-0.02-0.1%0.010.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.000.0%-0.06-0.3%-0.02-0.1%0.010.1%
Usd Price Per Share0.67-0.67-1.31-0.83-0.66-
Price to Earnings Ratio-7.84--7.84--18.74--11.76--11.60-
Price-to-Total Gains Ratio436.89-436.89--20.31-81.62-69.51-
Price to Book Ratio6.69-6.69-13.33-7.07-4.83-
Price-to-Total Gains Ratio436.89-436.89--20.31-81.62-69.51-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.2679115
Number of shares3732
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.00-0.02
Usd Total Gains Per Share0.00-0.02
Gains per Quarter (3732 shares)5.69-88.41
Gains per Year (3732 shares)22.78-353.63
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1023130-354-364
2046360-707-718
3068590-1061-1072
4091820-1415-1426
501141050-1768-1780
601371280-2122-2134
701591510-2475-2488
801821740-2829-2842
902051970-3183-3196
1002282200-3536-3550

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.09.00.00.0%0.09.00.00.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%5.04.00.055.6%5.04.00.055.6%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.09.00.0%0.00.09.00.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%5.04.00.055.6%5.04.00.055.6%

Fundamentals of Destiny Pharma PLC

About Destiny Pharma PLC

Destiny Pharma plc, a biotechnology company, focuses on the discovery, development, and commercialization of novel medicines to prevent serious infections in the United Kingdom. The company is involved in developing NTCD-M3 that is in Phase II clinical trial for the prevention of recurrent Clostridioides diffcile infections; XF-73 Nasal, which is in Phase II clinical trial for the prevention of post-surgical staphylococcal infection; and XF-73 Dermal that is in preclinical stage for the treatment of skin infections of antibiotic resistant bacteria, as well as superficial skin infections of antibiotic resistant bacteria. It also develops SPOR-COV, biotherapeutic product, which is in preclinical stage for the prevention of COVID-19 and other viral respiratory infections; and XF Drugs Research/Biofilms that is in preclinical stage for the treatment of antibiotic resistant biofilm and bacterial aggregate associated infections. In addition, the company is involved in the development of XF drugs for the treatment of respiratory, dermal, oral and ocular infections. Destiny Pharma plc has collaboration agreements with China Medical System Holdings Limited; SporeGen Limited; Sebela Pharmaceuticals; the University of Southampton; Aston University; the University of Sheffield; National Biofilms Innovation Centre; National Institute of Allergy and Infectious Diseases; Cystic Fibrosis Foundation; Cardiff University; and Tianjin Medical University. The company was incorporated in 1996 and is based in Brighton, the United Kingdom.

Fundamental data was last updated by Penke on 2024-04-21 03:34:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Destiny Pharma PLC.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Destiny Pharma PLC earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare Destiny Pharma PLC to the Biotechnology industry mean.
  • A Net Profit Margin of -4,209.5% means that -42.09 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Destiny Pharma PLC:

  • The MRQ is -4,209.5%. The company is making a huge loss. -2
  • The TTM is -4,209.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-4,209.5%TTM-4,209.5%0.0%
TTM-4,209.5%YOY-3,954.4%-255.1%
TTM-4,209.5%5Y-10,633.1%+6,423.6%
5Y-10,633.1%10Y-5,907.3%-4,725.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4,209.5%-200.1%-4,009.4%
TTM-4,209.5%-216.8%-3,992.7%
YOY-3,954.4%-288.3%-3,666.1%
5Y-10,633.1%-449.1%-10,184.0%
10Y-5,907.3%-605.5%-5,301.8%
1.1.2. Return on Assets

Shows how efficient Destiny Pharma PLC is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Destiny Pharma PLC to the Biotechnology industry mean.
  • -73.9% Return on Assets means that Destiny Pharma PLC generated -0.74 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Destiny Pharma PLC:

  • The MRQ is -73.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -73.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-73.9%TTM-73.9%0.0%
TTM-73.9%YOY-64.5%-9.5%
TTM-73.9%5Y-54.5%-19.4%
5Y-54.5%10Y-56.9%+2.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-73.9%-13.3%-60.6%
TTM-73.9%-12.8%-61.1%
YOY-64.5%-11.7%-52.8%
5Y-54.5%-13.9%-40.6%
10Y-56.9%-15.7%-41.2%
1.1.3. Return on Equity

Shows how efficient Destiny Pharma PLC is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Destiny Pharma PLC to the Biotechnology industry mean.
  • -85.3% Return on Equity means Destiny Pharma PLC generated -0.85 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Destiny Pharma PLC:

  • The MRQ is -85.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -85.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-85.3%TTM-85.3%0.0%
TTM-85.3%YOY-71.1%-14.2%
TTM-85.3%5Y-60.5%-24.7%
5Y-60.5%10Y-63.6%+3.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-85.3%-16.9%-68.4%
TTM-85.3%-16.1%-69.2%
YOY-71.1%-15.1%-56.0%
5Y-60.5%-19.3%-41.2%
10Y-63.6%-20.2%-43.4%

1.2. Operating Efficiency of Destiny Pharma PLC.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Destiny Pharma PLC is operating .

  • Measures how much profit Destiny Pharma PLC makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Destiny Pharma PLC to the Biotechnology industry mean.
  • An Operating Margin of -5,104.3% means the company generated -51.04  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Destiny Pharma PLC:

  • The MRQ is -5,104.3%. The company is operating very inefficient. -2
  • The TTM is -5,104.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-5,104.3%TTM-5,104.3%0.0%
TTM-5,104.3%YOY-4,764.7%-339.6%
TTM-5,104.3%5Y-12,883.6%+7,779.3%
5Y-12,883.6%10Y-7,157.6%-5,726.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5,104.3%-296.2%-4,808.1%
TTM-5,104.3%-232.5%-4,871.8%
YOY-4,764.7%-298.2%-4,466.5%
5Y-12,883.6%-492.1%-12,391.5%
10Y-7,157.6%-632.4%-6,525.2%
1.2.2. Operating Ratio

Measures how efficient Destiny Pharma PLC is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 51.04 means that the operating costs are 51.04 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Destiny Pharma PLC:

  • The MRQ is 51.044. The company is inefficient in keeping operating costs low. -1
  • The TTM is 51.044. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ51.044TTM51.0440.000
TTM51.044YOY47.647+3.396
TTM51.0445Y128.836-77.793
5Y128.83610Y71.576+57.261
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ51.0443.231+47.813
TTM51.0443.310+47.734
YOY47.6473.890+43.757
5Y128.8365.739+123.097
10Y71.5767.876+63.700

1.3. Liquidity of Destiny Pharma PLC.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Destiny Pharma PLC is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.57 means the company has 5.57 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Destiny Pharma PLC:

  • The MRQ is 5.565. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.565. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.565TTM5.5650.000
TTM5.565YOY7.739-2.174
TTM5.5655Y9.848-4.283
5Y9.84810Y13.631-3.782
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.5653.890+1.675
TTM5.5654.173+1.392
YOY7.7395.344+2.395
5Y9.8486.126+3.722
10Y13.6316.448+7.183
1.3.2. Quick Ratio

Measures if Destiny Pharma PLC is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Destiny Pharma PLC to the Biotechnology industry mean.
  • A Quick Ratio of 5.40 means the company can pay off 5.40 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Destiny Pharma PLC:

  • The MRQ is 5.398. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.398. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.398TTM5.3980.000
TTM5.398YOY7.289-1.891
TTM5.3985Y10.849-5.452
5Y10.84910Y13.730-2.881
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.3983.514+1.884
TTM5.3983.998+1.400
YOY7.2895.380+1.909
5Y10.8496.105+4.744
10Y13.7306.404+7.326

1.4. Solvency of Destiny Pharma PLC.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Destiny Pharma PLC assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Destiny Pharma PLC to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.13 means that Destiny Pharma PLC assets are financed with 13.3% credit (debt) and the remaining percentage (100% - 13.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Destiny Pharma PLC:

  • The MRQ is 0.133. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.133. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.133TTM0.1330.000
TTM0.133YOY0.093+0.040
TTM0.1335Y0.095+0.038
5Y0.09510Y0.094+0.001
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1330.339-0.206
TTM0.1330.336-0.203
YOY0.0930.271-0.178
5Y0.0950.366-0.271
10Y0.0940.389-0.295
1.4.2. Debt to Equity Ratio

Measures if Destiny Pharma PLC is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Destiny Pharma PLC to the Biotechnology industry mean.
  • A Debt to Equity ratio of 15.3% means that company has 0.15 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Destiny Pharma PLC:

  • The MRQ is 0.153. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.153. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.153TTM0.1530.000
TTM0.153YOY0.103+0.050
TTM0.1535Y0.105+0.048
5Y0.10510Y0.106-0.001
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1530.388-0.235
TTM0.1530.402-0.249
YOY0.1030.335-0.232
5Y0.1050.426-0.321
10Y0.1060.461-0.355

2. Market Valuation of Destiny Pharma PLC

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings Destiny Pharma PLC generates.

  • Above 15 is considered overpriced but always compare Destiny Pharma PLC to the Biotechnology industry mean.
  • A PE ratio of -7.84 means the investor is paying -7.84 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Destiny Pharma PLC:

  • The EOD is -3.151. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.841. Based on the earnings, the company is expensive. -2
  • The TTM is -7.841. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.151MRQ-7.841+4.690
MRQ-7.841TTM-7.8410.000
TTM-7.841YOY-18.743+10.902
TTM-7.8415Y-11.758+3.918
5Y-11.75810Y-11.601-0.158
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.151-2.264-0.887
MRQ-7.841-2.629-5.212
TTM-7.841-2.680-5.161
YOY-18.743-4.145-14.598
5Y-11.758-6.257-5.501
10Y-11.601-6.254-5.347
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Destiny Pharma PLC:

  • The EOD is -3.516. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -8.749. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -8.749. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.516MRQ-8.749+5.233
MRQ-8.749TTM-8.7490.000
TTM-8.749YOY-19.603+10.855
TTM-8.7495Y-11.650+2.901
5Y-11.65010Y-13.405+1.755
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.516-2.973-0.543
MRQ-8.749-3.333-5.416
TTM-8.749-3.553-5.196
YOY-19.603-5.605-13.998
5Y-11.650-8.376-3.274
10Y-13.405-8.865-4.540
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Destiny Pharma PLC is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 6.69 means the investor is paying 6.69 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of Destiny Pharma PLC:

  • The EOD is 2.687. Based on the equity, the company is underpriced. +1
  • The MRQ is 6.687. Based on the equity, the company is overpriced. -1
  • The TTM is 6.687. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD2.687MRQ6.687-3.999
MRQ6.687TTM6.6870.000
TTM6.687YOY13.327-6.641
TTM6.6875Y7.073-0.387
5Y7.07310Y4.834+2.239
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.6871.896+0.791
MRQ6.6872.115+4.572
TTM6.6872.093+4.594
YOY13.3272.884+10.443
5Y7.0733.542+3.531
10Y4.8343.916+0.918
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Destiny Pharma PLC compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1220.1220%-5.169+4321%-1.901+1652%0.889-86%
Book Value Per Share--8.0018.0010%7.879+2%9.986-20%8.048-1%
Current Ratio--5.5655.5650%7.739-28%9.848-43%13.631-59%
Debt To Asset Ratio--0.1330.1330%0.093+42%0.095+40%0.094+41%
Debt To Equity Ratio--0.1530.1530%0.103+49%0.105+46%0.106+44%
Dividend Per Share----0%-0%-0%-0%
Eps---6.823-6.8230%-5.602-18%-5.693-17%-3.980-42%
Free Cash Flow Per Share---6.115-6.1150%-5.356-12%-5.864-4%-3.913-36%
Free Cash Flow To Equity Per Share--0.2710.2710%-5.349+2077%-2.495+1022%0.498-46%
Gross Profit Margin--1.5121.5120%1.446+5%1.436+5%1.242+22%
Intrinsic Value_10Y_max---69.471--------
Intrinsic Value_10Y_min---76.248--------
Intrinsic Value_1Y_max---6.114--------
Intrinsic Value_1Y_min---6.866--------
Intrinsic Value_3Y_max---19.017--------
Intrinsic Value_3Y_min---21.422--------
Intrinsic Value_5Y_max---32.697--------
Intrinsic Value_5Y_min---36.736--------
Market Cap2049205936.000-149%5099186864.0005099186864.0000%10007749920.000-49%6328710425.600-19%5025055383.111+1%
Net Profit Margin---42.095-42.0950%-39.544-6%-106.331+153%-59.073+40%
Operating Margin---51.043-51.0430%-47.647-7%-128.836+152%-71.576+40%
Operating Ratio--51.04451.0440%47.647+7%128.836-60%71.576-29%
Pb Ratio2.687-149%6.6876.6870%13.327-50%7.073-5%4.834+38%
Pe Ratio-3.151+60%-7.841-7.8410%-18.743+139%-11.758+50%-11.601+48%
Price Per Share21.500-149%53.50053.5000%105.000-49%66.400-19%52.722+1%
Price To Free Cash Flow Ratio-3.516+60%-8.749-8.7490%-19.603+124%-11.650+33%-13.405+53%
Price To Total Gains Ratio175.573-149%436.892436.8920%-20.312+105%81.617+435%69.509+529%
Quick Ratio--5.3985.3980%7.289-26%10.849-50%13.730-61%
Return On Assets---0.739-0.7390%-0.645-13%-0.545-26%-0.569-23%
Return On Equity---0.853-0.8530%-0.711-17%-0.605-29%-0.636-25%
Total Gains Per Share--0.1220.1220%-5.169+4321%-1.901+1652%0.889-86%
Usd Book Value--9502784.7689502784.7680%9357346.207+2%11859804.600-20%9559033.722-1%
Usd Book Value Change Per Share--0.0020.0020%-0.064+4321%-0.024+1652%0.011-86%
Usd Book Value Per Share--0.1000.1000%0.098+2%0.124-20%0.100-1%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.085-0.0850%-0.070-18%-0.071-17%-0.050-42%
Usd Free Cash Flow---7262963.632-7262963.6320%-6361546.107-12%-6964528.912-4%-4647739.917-36%
Usd Free Cash Flow Per Share---0.076-0.0760%-0.067-12%-0.073-4%-0.049-36%
Usd Free Cash Flow To Equity Per Share--0.0030.0030%-0.067+2077%-0.031+1022%0.006-46%
Usd Market Cap25535155.168-149%63540967.51263540967.5120%124706571.753-49%78862060.613-19%62617215.129+1%
Usd Price Per Share0.268-149%0.6670.6670%1.308-49%0.827-19%0.657+1%
Usd Profit---8104097.331-8104097.3310%-6653526.028-18%-6761055.486-17%-4727011.261-42%
Usd Revenue--192521.204192521.2040%168258.391+14%151496.601+27%84164.778+129%
Usd Total Gains Per Share--0.0020.0020%-0.064+4321%-0.024+1652%0.011-86%
 EOD+2 -6MRQTTM+0 -0YOY+14 -205Y+14 -2010Y+9 -25

3.2. Fundamental Score

Let's check the fundamental score of Destiny Pharma PLC based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.151
Price to Book Ratio (EOD)Between0-12.687
Net Profit Margin (MRQ)Greater than0-42.095
Operating Margin (MRQ)Greater than0-51.043
Quick Ratio (MRQ)Greater than15.398
Current Ratio (MRQ)Greater than15.565
Debt to Asset Ratio (MRQ)Less than10.133
Debt to Equity Ratio (MRQ)Less than10.153
Return on Equity (MRQ)Greater than0.15-0.853
Return on Assets (MRQ)Greater than0.05-0.739
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Destiny Pharma PLC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.321
Ma 20Greater thanMa 5023.163
Ma 50Greater thanMa 10030.345
Ma 100Greater thanMa 20048.438
OpenGreater thanClose21.750
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in GBP. All numbers in thousands.

Summary
Total Assets8,796
Total Liabilities1,170
Total Stockholder Equity7,626
 As reported
Total Liabilities 1,170
Total Stockholder Equity+ 7,626
Total Assets = 8,796

Assets

Total Assets8,796
Total Current Assets6,510
Long-term Assets2,286
Total Current Assets
Cash And Cash Equivalents 4,903
Net Receivables 1,410
Other Current Assets 196
Total Current Assets  (as reported)6,510
Total Current Assets  (calculated)6,510
+/-0
Long-term Assets
Property Plant Equipment 25
Intangible Assets 2,261
Long-term Assets  (as reported)2,286
Long-term Assets  (calculated)2,286
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,170
Long-term Liabilities173
Total Stockholder Equity7,626
Total Current Liabilities
Accounts payable 173
Other Current Liabilities 997
Total Current Liabilities  (as reported)1,170
Total Current Liabilities  (calculated)1,170
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)173
Long-term Liabilities  (calculated)0
+/- 173
Total Stockholder Equity
Common Stock733
Retained Earnings -26,151
Other Stockholders Equity 33,044
Total Stockholder Equity (as reported)7,626
Total Stockholder Equity (calculated)7,626
+/-0
Other
Capital Stock733
Cash and Short Term Investments 4,903
Common Stock Shares Outstanding 70,201
Liabilities and Stockholders Equity 8,796
Net Debt -4,903
Net Invested Capital 7,626
Net Tangible Assets 5,365
Net Working Capital 5,340
Property Plant and Equipment Gross 152



Balance Sheet

Currency in GBP. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312003-12-312002-12-312001-12-312001-03-312000-03-31
> Total Assets 
261
82
288
125
653
3,045
5,646
4,190
6,612
4,902
3,422
2,200
1,116
661
2,430
1,345
1,699
17,083
13,058
8,557
13,705
8,283
8,796
8,7968,28313,7058,55713,05817,0831,6991,3452,4306611,1162,2003,4224,9026,6124,1905,6463,04565312528882261
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
660
2,429
1,343
1,698
17,061
13,028
8,525
11,425
5,985
6,510
6,5105,98511,4258,52513,02817,0611,6981,3432,4296600000000000000
       Cash And Cash Equivalents 
222
50
280
91
444
2,744
5,184
3,460
6,116
4,632
3,174
1,952
912
537
2,004
1,119
1,481
11,724
7,061
7,480
9,744
4,646
4,903
4,9034,6469,7447,4807,06111,7241,4811,1192,0045379121,9523,1744,6326,1163,4605,1842,7444449128050222
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,000
5,000
0
0
0
0
00005,0005,00000000000000000000
       Net Receivables 
21
22
3
32
209
299
461
727
493
257
244
246
164
93
397
201
217
277
931
911
1,172
992
1,410
1,4109921,172911931277217201397931642462442574937274612992093232221
       Other Current Assets 
0
0
0
0
0
0
0
0
0
6
0
0
38
30
28
23
0
337
967
134
508
348
196
196348508134967337023283038006000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
3
1
22
30
33
2,280
2,297
2,286
2,2862,2972,28033302213100000000000000
       Property Plant Equipment 
18
10
5
2
0
3
1
2
3
7
5
3
1
1
1
3
1
22
30
33
18
36
25
2536183330221311135732130251018
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,261
2,261
2,261
2,2612,2612,26100000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000
> Total Liabilities 
88
39
278
73
312
481
567
460
573
367
149
190
140
306
458
94
155
397
802
798
1,268
773
1,170
1,1707731,26879880239715594458306140190149367573460567481312732783988
   > Total Current Liabilities 
88
39
278
73
222
481
567
460
573
367
149
190
140
306
458
94
155
397
802
798
1,268
773
1,170
1,1707731,26879880239715594458306140190149367573460567481222732783988
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,000
5,000
0
0
0
0
00005,0005,00000000000000000000
       Accounts payable 
66
24
40
2
7
128
225
177
315
95
50
88
68
74
302
39
58
152
404
514
726
218
173
1732187265144041525839302746888509531517722512872402466
       Other Current Liabilities 
22
15
238
70
185
353
342
283
258
272
98
101
72
232
156
55
0
246
398
285
543
555
997
9975555432853982460551562327210198272258283342353185702381522
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
404
514
726
218
173
173218726514404000000000000000000
> Total Stockholder Equity
173
43
10
52
341
2,565
5,080
3,730
6,039
4,535
3,274
2,011
976
355
1,972
1,251
1,544
16,686
12,257
7,759
12,436
7,509
7,626
7,6267,50912,4367,75912,25716,6861,5441,2511,9723559762,0113,2744,5356,0393,7305,0802,565341521043173
   Common Stock
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
436
436
439
598
599
733
73359959843943643611111111100000000
   Retained Earnings Total Equity00000000000000000000000
   Accumulated Other Comprehensive Income 000-85-67-57-55-54-5300000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,335
17,292
17,292
17,296
27,086
0
0
0027,08617,29617,29217,29218,3350000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,349
17,359
17,296
27,086
27,091
33,044
33,04427,09127,08617,29617,35917,34900000000000000000



Balance Sheet

Currency in GBP. All numbers in thousands.




Cash Flow

Currency in GBP. All numbers in thousands.




Income Statement

Currency in GBP. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue154
Cost of Revenue-12
Gross Profit142142
 
Operating Income (+$)
Gross Profit142
Operating Expense-7,874
Operating Income-7,886-7,732
 
Operating Expense (+$)
Research Development3,272
Selling General Administrative7,931
Selling And Marketing Expenses3,329
Operating Expense7,87414,532
 
Net Interest Income (+$)
Interest Income65
Interest Expense-65
Other Finance Cost-65
Net Interest Income65
 
Pretax Income (+$)
Operating Income-7,886
Net Interest Income65
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-7,712-8,061
EBIT - interestExpense = -7,951
-7,712
-6,439
Interest Expense65
Earnings Before Interest and Taxes (EBIT)-7,886-7,647
Earnings Before Interest and Taxes (EBITDA)-7,874
 
After tax Income (+$)
Income Before Tax-7,712
Tax Provision--1,208
Net Income From Continuing Ops-6,504-6,504
Net Income-6,504
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses7,886
Total Other Income/Expenses Net175-65
 

Technical Analysis of Destiny Pharma PLC
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Destiny Pharma PLC. The general trend of Destiny Pharma PLC is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Destiny Pharma PLC's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Destiny Pharma PLC.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 24.50 < 25.00 < 28.00.

The bearish price targets are: 15.55.

Tweet this
Destiny Pharma PLC Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Destiny Pharma PLC. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Destiny Pharma PLC Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Destiny Pharma PLC. The current macd is -3.10164406.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Destiny Pharma PLC price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Destiny Pharma PLC. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Destiny Pharma PLC price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Destiny Pharma PLC Daily Moving Average Convergence/Divergence (MACD) ChartDestiny Pharma PLC Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Destiny Pharma PLC. The current adx is 30.45.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Destiny Pharma PLC shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Destiny Pharma PLC Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Destiny Pharma PLC. The current sar is 15.88.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Destiny Pharma PLC Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Destiny Pharma PLC. The current rsi is 38.32. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Destiny Pharma PLC Daily Relative Strength Index (RSI) ChartDestiny Pharma PLC Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Destiny Pharma PLC. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Destiny Pharma PLC price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Destiny Pharma PLC Daily Stochastic Oscillator ChartDestiny Pharma PLC Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Destiny Pharma PLC. The current cci is -38.8255863.

Destiny Pharma PLC Daily Commodity Channel Index (CCI) ChartDestiny Pharma PLC Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Destiny Pharma PLC. The current cmo is -14.44125301.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Destiny Pharma PLC Daily Chande Momentum Oscillator (CMO) ChartDestiny Pharma PLC Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Destiny Pharma PLC. The current willr is -52.20883534.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Destiny Pharma PLC is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Destiny Pharma PLC Daily Williams %R ChartDestiny Pharma PLC Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Destiny Pharma PLC.

Destiny Pharma PLC Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Destiny Pharma PLC. The current atr is 2.46731822.

Destiny Pharma PLC Daily Average True Range (ATR) ChartDestiny Pharma PLC Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Destiny Pharma PLC. The current obv is -981,192.

Destiny Pharma PLC Daily On-Balance Volume (OBV) ChartDestiny Pharma PLC Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Destiny Pharma PLC. The current mfi is 35.39.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Destiny Pharma PLC Daily Money Flow Index (MFI) ChartDestiny Pharma PLC Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Destiny Pharma PLC.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-11MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-18MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Destiny Pharma PLC Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Destiny Pharma PLC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.321
Ma 20Greater thanMa 5023.163
Ma 50Greater thanMa 10030.345
Ma 100Greater thanMa 20048.438
OpenGreater thanClose21.750
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Destiny Pharma PLC with someone you think should read this too:
  • Are you bullish or bearish on Destiny Pharma PLC? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Destiny Pharma PLC? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Destiny Pharma PLC

I send you an email if I find something interesting about Destiny Pharma PLC.


Comments

How you think about this?

Leave a comment

Stay informed about Destiny Pharma PLC.

Receive notifications about Destiny Pharma PLC in your mailbox!